GL1X · GenesisL1 explorer

Research workbench

Dini-sulerythrin treated by hydrogen perxoide

Analyse Dini-sulerythrin treated by hydrogen perxoide in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7O9C
Type
protein
Length
287 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Sulerythrin
UniProt
F9VPE5
Ligands
NI, CL
Pockets
2 · best druggability 0.43

Structure

x-ray diffraction · 2 distinct chains · 81% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASulerythrinprotein14282% helix, 0% strandF9VPE5
BSulerythrinprotein14581% helix, 0% strandF9VPE5

Ligands and binding sites

  • NI · Nickel (II) ion · metal · 5 copies · chains A, B
  • CL · Chloride ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1910.430.7919empty
2820.410.7817empty

Interfaces

1 interface between chains.

  • A–B · 3529 Ų buried · 54 hydrogen bonds · protein-protein

Compared structures

  • 7O9C · diNi-sulerythrin treated by hydrogen perxoide · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.